While Issuing Warnings About AI-Made Bioweapons, Anthropic Quietly Set Up an AI-Run, Robot-Operated Biology Lab Here in the US

Anthropic's move highlights a growing tension in the AI industry between publicly warning about catastrophic risks—like AI-assisted bioweapon creation—and privately pursuing projects that could accelerate those very capabilities. The disclosure raises questions about corporate transparency, self-regulation credibility, and whether AI safety rhetoric matches actual internal practices, which matters to regulators, competitors, and the public trying to gauge real risk levels.

• Anthropic has been vocal about AI-enabled bioweapon risks while simultaneously building an AI-directed, robot-operated biology lab in the US.
• The apparent contradiction between public risk warnings and internal lab work raises concerns about transparency and consistency in AI safety messaging.
• The story could intensify scrutiny from regulators and the public over how AI labs balance safety advocacy with capability development in sensitive domains like biotech.